Following the first 1000 days of life that span from conception to two years of age, the next 1000 days of a child's life from 2–5 years of age offer a window of opportunity to promote nurturing and ...

In a global landscape defined by polycrisis, children are being failed. To address this failure, we ask an ambitious yet fundamental question: how do we create child-inclusive societies where every ...

Neurodiversity is a concept that embraces the different ways that the human brain processes information, functions, and presents behaviourally.1 Instead of thinking in terms of a medical disability ...

The centrality of the first 1000 days—from conception to 2 years of age—for early childhood development is recognised in global research, policy, and practice as a crucial period for physical growth ...

Demand for mental health services exceeds available resources globally, and access to diagnosis and evidence-based treatment ...

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar ...

For decades, researchers from all obesity-related disciplines have been observing the escalating prevalence of people living ...

The G20 Leaders’ Summit in Rio de Janeiro on Nov 18–19 will address global health, but uncertainty over multilateralism under a new US President looms large. John Zarocostas reports.

The world's first self-amplifying mRNA vaccine, or replicon vaccine, was administered in Japan to prevent SARS-CoV-2 infection.1 Similar to other infodemics related to COVID-19 vaccines,2 ...

Donald Trump's decisive re-election as US President on Nov 5 puts many aspects of health and science in a deeply concerning position. Although there is broader alarm about his openly authoritarian ...

Earlier this year, Jarno Habicht, the WHO Representative in Ukraine, described the situation there as a “humanitarian crisis ...

We fully endorse the Editorial1 on the negative opinion of the European Medicines Agency of the use of lecanemab for the treatment of early Alzheimer's disease. Investigators from the European ...